Rong Qi

About this team member

Rong earned her Ph.D. in Pharmaceutical Science from China Pharmaceutical University in 2004 and is currently a professor at Peking University. Her  research focuses on PEG-conjugated dendrimers as in-vitro and in-vivo DNA and RNA delivery vectors. She  is collaborating with our group on the endocytosis mechanism of polycationic dendrimer-DNA polyplexes using biochemistry techniques to up- or down-regulate some crucial receptors or proteins, which are related to internalization pathways of the polyplexes.

Rona and Mark at IDS10 in Weihai, China Summer 2017.

Publications

• G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol R. Qi, Y. Z. Li, C. Chen, Y. N. Cao, M. M. Yu, L. Xu, B. He, X. Jie, W. W. Shen, Y. N. Wang, M. A. van Dongen, G. Q. Lui, M. M. Banaszak Holl, Q. Zhang, X. Ke Journal of Controlled Release 2015 210 160-168
• Efficient in vitro siRNA delivery and Intramuscular Gene Silencing using PEG-Modified PAMAM Dendrimers Y. Tang, Y.-B. Li, B. Wang, R.-Y. Lin, M. van Dongen, D. M. Zurcher, X.-Y. Gu, M. M. Banaszak Holl, G. Liu, R. Qi Molecular Pharmaceutics 2012 9 1812-1821
• The Mechanism of Polyplexes Internalization into Cells: Testing the GM1/Caveolin-1-Mediated Lipid Raft Mediated Endocytosis Pathway R. Qi, D. Mullen, J. R. Baker, M. M. Banaszak Holl Molecular Pharmaceutics 2010 7 267-279.